13674
Over a 3-week course of IL-2 therapy, in most patients the binding patterns of AP-1 , Sp1 , and NF-kappaB proteins changed to resemble those seen in PBMC activated by IL-2 in vitro.
 protein: NF-kappaB; cell type: PBMC; protein: Sp1; protein: IL-2; protein: IL-2; protein: AP-1
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: cell line, protein, RNA, DNA, cell type 
Text: {0} 
 Entities: NF-kappaB, PBMC, Sp1, IL-2, IL-2, AP-1 
Answer:
 protein: NF-kappaB; cell type: PBMC; protein: Sp1; protein: IL-2; protein: IL-2; protein: AP-1